Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Moderate to Severe Conjunctivochalasis
PHASE2CompletedINTERVENTIONAL
Enrollment
62
Participants
Timeline
Start Date
July 31, 2016
Primary Completion Date
June 30, 2019
Study Completion Date
June 30, 2019
Conditions
Conjunctivochalasis
Interventions
DRUG
LO2A
eye drop solution.
DRUG
Saline
Placebo
Trial Locations (3)
Unknown
Rambam, Haifa
Hadassah, Jerusalem
Ichilov Tel Aviv hospital, Tel Aviv
All Listed Sponsors
lead
Ocuwize LTD
INDUSTRY
NCT02804191 - Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Moderate to Severe Conjunctivochalasis | Biotech Hunter | Biotech Hunter